On 9 November, the AIMS MEDICAL team, located in the Tecnocampus incubator, played a leading role in the PECT Mataró-Maresme…
admina14/11/2023
AIMS-Medical S.L. Obtains Funding to Boost its Technology. At AIMS-Medical we are back from holidays with good news. The spin-off…
admina27/09/2023
It has been a pleasure to attend the second edition of the TAULÍ HEALTH ARTIFICIAL INTELLIGENCE SYMPOSIUM organised by Parc…
admina22/06/2023
We had the honour of participating in the conference promoted by Unió Catalana d'Hospitals on Artificial Intelligence AI: a mosaic…
admina22/06/2023
The prevalence of oropharyngeal dysphagia in hospitalised elderly is 47%. Among them, 98.7% have nutritional risk, 75.3% dehydration and 32.3%…
admina22/06/2023
AIMS-Medical Spin-off will be present at the World Dysphagia Summit and 31st DRS conference, San Francisco (USA) 2023 to present…
admina01/03/2023
In January 2023 the Spin-off AIMS-Medical received the invention patent grant from the Spanish Patent and Trademark Office.
admina01/01/2023
Oropharyngeal dysphagia is underdiagnosed and current screening is costly. We aimed: (a) to develop an expert system (ES) based on…
admina28/12/2022
AIMS-OD provides systematic, real-time OD screening, enabling the selection of the most appropriate diagnostic and therapeutic strategies for each patient.
admina12/12/2022
